• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

CMS Finalizes 2019 Medicare Clinical Lab Payment Determinations

healthindustrywashingtonwatchNovember 28, 2018

Tag: CMS , Medicare Clinical , CLFS

CMS has released its final 2019 Medicare clinical laboratory fee schedule (CLFS) payment determinations for new and reconsidered clinical lab test codes.  Specifically, CMS finalized the basis for establishing the payment rate (crosswalking or gapfilling), along with the agency’s rationale for the decision.

Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

Previous:Italy free to reimburse off-label Avastin, rules EU court

Next:Natera and Neon Therapeutics Announce Clinical Trial Collaboration

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

CMS Finalizes 2019 Medicare Clinical Lab Payment Determinations | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

GCMS 2400™ Platform

GCMS 2400™ Platform
CMS-20D Digital Hotplate Stirrer

CMS-20D Digital Hotplate Stirrer
2.5L LCMS Methanol

2.5L LCMS Methanol
Sodium Starch Glycolate（CMS-Na）

Sodium Starch Glycolate（CMS-Na）
4L LCMS Methanol

4L LCMS Methanol
CMS System

CMS System
CMS121 CAS No.:1353224-53-9 98.0% purity min.

CMS121 CAS No.:1353224-53-9 98.0% purity min.
4L LCMS Acetonitrile

4L LCMS Acetonitrile
Premium Hotplate Stirrer CMS-20A

Premium Hotplate Stirrer CMS-20A
CMS-30D Digital Hotplate Stirrer

CMS-30D Digital Hotplate Stirrer

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service